Novartis Partners with Generate in $1B Biotech Deal
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
- Latest
- Trending
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
The potential of AI in revolutionizing disease prevention and management and the challenges it faces in the healthcare system.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.